Valvular heart disease cardiac catheterization

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Valvular heart disease Microchapters
Patient Information
Classification Aortic stenosis Aortic regurgitation Mitral stenosis Mitral valve prolapse Mitral regurgitation Tricuspid stenosis Tricuspid regurgitation Pulmonary stenosis Pulmonary regurgitation
Differential Diagnosis

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

Class I

"1. Cardiac catheterization for hemodynamic assessment is recommended in symptomatic patients when noninvasive tests are inconclusive or when there is a discrepancy between the findings on noninvasive testing and physical examination regarding severity of the valve lesion. (Level of Evidence: C)"

2006 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease - Indications for Cardiac Catheterization in Aortic Stenosis Patients (DO NOT EDIT)

Class I

"1. Coronary angiography is recommended before Aortic valve replacement in patients with aortic stenosis at risk for Coronary heart disease. (Level of Evidence: B) "

"2. Cardiac catheterization for hemodynamic measurements is recommended for assessment of severity of AS in symptomatic patients when noninvasive tests are inconclusive or when there is a discrepancy between noninvasive tests and clinical findings regarding severity of AS. (Level of Evidence: C)"

"3. Coronary angiography is recommended before AVR in patients with Aortic stenosis for whom a pulmonary autograft (Ross procedure) is contemplated and if the origin of the coronary arteries was not identified by noninvasive technique. (Level of Evidence: C)"

Class III (Harm)

"1. Cardiac catheterization for hemodynamic measurements is not recommended for the assessment of severity of AS before AVR when noninvasive tests are adequate and concordant with clinical findings. (Level of Evidence: C) "

"2. Cardiac catheterization for hemodynamic measurements is not recommended for the assessment of LV function and severity of AS in asymptomatic patients. (Level of Evidence: C) "